Hwang‐Phill Kim

Morphological Adjustment of Senescent Cells by Modulating Caveolin-1 Status

Kyung A Cho, Sung Jin Ryu, Yoon Sin Oh et al. · Journal of Biological Chemistry · 2004 · 219 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib

Ahrum Min, Seock‐Ah Im, Young‐Kwang Yoon et al. · Molecular Cancer Therapeutics · 2013 · 141 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2

Hwang‐Phill Kim, Young‐Kwang Yoon, Jin‐Won Kim et al. · PLoS ONE · 2009 · 117 citations · Full text

Medicine, Oncology, Pharmacology +15

The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines

Jin Won Kim, Hwang‐Phill Kim, Seock‐Ah Im et al. · Cancer Letters · 2008 · 117 citations

Medicine, Oncology, Pharmacology +17

OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells

Mi‐Jung Kim, Hyun-Jin Nam, Hwang‐Phill Kim et al. · Cancer Letters · 2013 · 116 citations

Medicine, Oncology, Pharmacology +9